US proposal to halve biosimilar development costs for Biocon, top exec says
Biosimilars are copies of costlier biological drugs usedto treat major illnesses such as cancer, rheumatoid arthritis,psoriasis and diabetes
Biosimilars are copies of costlier biological drugs usedto treat major illnesses such as cancer, rheumatoid arthritis,psoriasis and diabetes